4.7 Article

Plasmodium falciparum Merozoite Surface Antigen, PfRH5, Elicits Detectable Levels of Invasion-Inhibiting Antibodies in Humans

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 208, Issue 10, Pages 1679-1687

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jit385

Keywords

RH2; RH5; malaria; vaccine candidate; invasion; Plasmodium falciparum; recombinant protein expression

Funding

  1. National Institutes of Health (NIH) [K12-HD00850, 5K12-HD052896]
  2. Boston Children's Hospital Office of Faculty Development
  3. Shore Fellowship
  4. Centers for Disease Control and Prevention [R36 CK000119-01]
  5. Epidemiology of Infectious Disease and Biodefense Training Grant [2T32 AI007535-12]
  6. NIH [R03 TW008053]

Ask authors/readers for more resources

Plasmodium falciparum is an intracellular protozoan parasite that infects erythrocytes and hepatocytes. The blood stage of its life cycle causes substantial morbidity and mortality associated with millions of infections each year, motivating an intensive search for potential components of a multi-subunit vaccine. In this study, we present data showing that antibodies from natural infections can recognize a recombinant form of the relatively conserved merozoite surface antigen, PfRH5. Furthermore, we performed invasion inhibition assays on clinical isolates and laboratory strains of P. falciparum in the presence of affinity purified antibodies to RH5 and show that these antibodies can inhibit invasion in vitro.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available